diabetes glp-1 vs sglt2 inhibitors or receptor agonists as second-line therapy in | VHRM SGLT2 vs GLP-1: Individualizing Diabetes,
Description
Call: 419-843-6663 You can also complete our confidential form to get started.

We should talk about ways to modify this if it's something you care about, and maybe you should care about it if it's going to shorten your lifespan. That discussion needs to occur early on, not when you finally notice when the patient can't get through your office door

PIONEER 1 Investigators

We thank the study participants, the dieticians Jane Hjort and Stine Rasmussen, Hvidovre Hospital and lab technician Lene Albk, University of Copenhagen

Were going to break down the neurological impact of GLP-1s on your brains reward systems and simplify the science behind why you might feel a bit disconnected from things that used to bring you joy
